Nicole Conci

PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors

Filippo Gustavo Dall’Olio, Francesco Gelsomino, Nicole Conci et al. · Clinical Lung Cancer · 2021 · 67 citations

Prognostic Biomarkers, Cancer Immunosurveillance, Pd-l1 Expression +12

Baseline total metabolic tumour volume on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography-computed tomography as a promising biomarker in patients with advanced non–small cell lung cancer treated with first-line pembrolizumab

Filippo Gustavo Dall’Olio, Diletta Calabrò, Nicole Conci et al. · European Journal of Cancer · 2021 · 50 citations

First-line Pembrolizumab, Promising Biomarker, Oncology +8

RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion

Mihaela Aldea, Arianna Marinello, M. Duruisseaux et al. · Journal of Thoracic Oncology · 2023 · 42 citations · Full text

Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients – A single centre experience

Filippo Gustavo Dall’Olio, Nicole Conci, Giulio Rossi et al. · Lung Cancer · 2020 · 38 citations

Sequencing, Cancer Detection, Advanced Lung Disease +11

Metabolic Tumor Volume Assessed by 18F FDG–PET CT Scan as a Predictive Biomarker for Immune Checkpoint Blockers in Advanced NSCLC and Its Biological Correlates

Filippo Gustavo Dall’Olio, Wael Zrafi, Véronique Roelants et al. · Clinical Cancer Research · 2024 · 12 citations · Full text